Changing the enzalutamide form from a capsule to a tablet improves the adherence of medicine intake: A case of a significant decrease in the prostate‐specific antigen level and improvement in radiographic findings.

MLA

Kawahara, Takashi, et al. “Changing the Enzalutamide Form from a Capsule to a Tablet Improves the Adherence of Medicine Intake: A Case of a Significant Decrease in the Prostate‐specific Antigen Level and Improvement in Radiographic Findings.” IJU Case Reports, vol. 2, no. 3, May 2019, pp. 143–45. EBSCOhost, https://doi.org/10.1002/iju5.12062.

APA

Kawahara, T., Ninomiya, S., Miyoshi, Y., Yao, M., & Uemura, H. (2019). Changing the enzalutamide form from a capsule to a tablet improves the adherence of medicine intake: A case of a significant decrease in the prostate‐specific antigen level and improvement in radiographic findings. IJU Case Reports, 2(3), 143–145. https://doi.org/10.1002/iju5.12062

Chicago

Kawahara, Takashi, Sahoko Ninomiya, Yasuhide Miyoshi, Masahiro Yao, and Hiroji Uemura. 2019. “Changing the Enzalutamide Form from a Capsule to a Tablet Improves the Adherence of Medicine Intake: A Case of a Significant Decrease in the Prostate‐specific Antigen Level and Improvement in Radiographic Findings.” IJU Case Reports 2 (3): 143–45. doi:10.1002/iju5.12062.